- Home
- PLRX vs DXYZ Comparison
PLRX vs DXYZ Comparison
Compare PLRX & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLRX | DXYZ |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | |
| Employees | 49 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.7M | 974.9M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PLRX | DXYZ |
|---|---|---|
| Price | $1.08 | $30.58 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.67 | N/A |
| AVG Volume (30 Days) | 360.5K | ★ 797.9K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.02 | $19.71 |
| 52 Week High | $1.95 | $72.87 |
Technical Indicators
Market Signals| Indicator | PLRX | DXYZ |
|---|---|---|
| Relative Strength Index (RSI) | 43.14 | 47.98 |
| Support Level | $1.02 | $30.15 |
| Resistance Level | $1.37 | $34.13 |
| Average True Range (ATR) | 0.05 | 1.28 |
| MACD | -0.00 | -0.39 |
| Stochastic Oscillator | 9.09 | 29.45 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
About DXYZ Destiny Tech100 Inc.
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It is designed to be an investment portfolio of the Top 100 High-Growth Tech Companies.